Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)

GlobeNewswire Europe

Details of the person subject to the disclosure requirement
Name: Hunziker,  Erich
Professional role: Person with executive functions:   Member of administrative or supervisory body
   
Designation of the financial instrument
ISIN: CH0038389992
Designation: Registered share BB Biotech AG
   
Details of the transaction
Type of transaction: Buy
Date: 26.11.2013
Place (stock exchange): SIX Swiss Exchange
Price: 138.12
Currency: CHF
Quantity: 3666
Business volume: 506350.12
   
Details of the company with the publishing obligation:
Issuer:
BB Biotech AG
Vordergasse 3
CH-8200   Schaffhausen
Switzerland
ISIN: CH0038389992
WKN: 888509



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: BB Biotech AG via GlobeNewswire

HUG#1746233

Rates